Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page
- Check6 days agoChange DetectedGuangdong has been added to the Locations section as a new trial site. This update expands the study's geographic reach and provides participation details for the new site.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label was updated to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check35 days agoChange DetectedA new note indicates PubMed publications are automatically filled and may not relate to the study, and the revision stamp updated to v3.3.1, replacing the older v3.2.0 wording.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding status notice on the page has been removed, and the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedStudy Details page shows a visual/layout update (reorganized panels and header styling) with no changes to the study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check85 days agoChange DetectedMajor addition of a government funding lapse notice and operating-status details plus a version bump to v3.2.0; removal of the previous v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.